Wali Adil Farooq, Pillai Jayachithra Ramakrishna, Talath Sirajunisa, Shivappa Pooja, Sridhar Sathvik Belagodu, El-Tanani Mohamed, Rangraze Imran Rashid, Mohamed Omnia Ibrahim, Al Ani Nowar Nizar
Department of Pharmaceutical Chemistry, College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
Translational Medicinal Research Centre, Department of Biochemistry, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
Curr Issues Mol Biol. 2025 Jan 6;47(1):30. doi: 10.3390/cimb47010030.
Extensive investigation has been conducted on plant-based resources for their pharmacological usefulness, including various cancer types. The scope of this review is wider than several studies with a particular focus on breast cancer, which is an international health concern while studying sources of flavonoids, carotenoids, polyphenols, saponins, phenolic compounds, terpenoids, and glycosides apart from focusing on nursing. Important findings from prior studies are synthesized to explore these compounds' sources, mechanisms of action, complementary and synergistic effects, and associated side effects. It was reviewed that the exposure to certain doses of catechins, piperlongumine, lycopene, isoflavones and cucurbitacinfor a sufficient period can provide profound anticancer benefits through biological events such as cell cycle arrest, cells undergoing apoptosis and disruption of signaling pathways including, but not limited to JAK-STAT3, HER2-integrin, and MAPK. Besides, the study also covers the potential adverse effects of these phytochemicals. Regarding mechanisms, the widest attention is paid to Complementary and synergistic strategies are discussed which indicate that it would be realistic to alter the dosage and delivery systems of liposomes, nanoparticles, nanoemulsions, and films to enhance efficacy. Future research directions include refining these delivery approaches, further elucidating molecular mechanisms, and conducting clinical trials to validate findings. These efforts could significantly advance the role of phytocompounds in breast cancer management.
人们对植物性资源的药理作用进行了广泛研究,包括对各种癌症类型的研究。本综述的范围比一些特别关注乳腺癌的研究更广,乳腺癌是一个国际健康问题,在研究黄酮类化合物、类胡萝卜素、多酚、皂苷、酚类化合物、萜类化合物和糖苷的来源时,除了关注护理外,还涉及这些方面。综合先前研究的重要发现,以探索这些化合物的来源、作用机制、互补和协同效应以及相关副作用。据综述,在足够长的时间内接触一定剂量的儿茶素、胡椒碱、番茄红素、异黄酮和葫芦素,可通过细胞周期停滞、细胞凋亡以及信号通路(包括但不限于JAK-STAT3、HER2-整合素和MAPK)的破坏等生物学事件提供深远的抗癌益处。此外,该研究还涵盖了这些植物化学物质的潜在不良反应。关于作用机制,最受关注的是讨论了互补和协同策略,这表明改变脂质体、纳米颗粒、纳米乳液和薄膜的剂量和递送系统以提高疗效是可行的。未来的研究方向包括完善这些递送方法、进一步阐明分子机制以及进行临床试验以验证研究结果。这些努力可显著推进植物化合物在乳腺癌管理中的作用。